Anticancer agent 260
Anticanceragent 260 is an orally bioavailable small molecule demonstrating in vitro antiproliferative activity against HCT-116, MIA-PaCa2, and MDA-MB231 cancer cell lines. It also exhibits in vivo relevant properties including analgesic and anti-inflammatory effects, alongside documented induction of ulcer formation and lipid peroxidation in research models.
Product Specifications
CAS Number
345994-70-9
Field of Research
Immunology & Inflammation, Metabolism Research, Signal Transduction
Smiles
N=1N=C (OC1C=2C=CN=CC2) C=3C=CC=CC3C
Molecular Formula
C14H11N3O
Molecular Weight
237.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E40MAV105 50 µg
Recombinant Human anti-COVID-19/SARS-CoV-2 NTD Protein Monoclonal Antibody
Sign In for Pricing
View Details 
31-1846-0.5 0.5 mg
Hamster Anti-Mouse CD28-LENATM (Low Endotoxin No Azide)
Sign In for Pricing
View Details 148775 100 µg
NPFFR1, Control Peptide (Neuropeptide FF Receptor 1, G-protein Coupled Receptor 147, RFamide-related Peptide Receptor OT7T022, GPR147, NPFF1, FLJ10751)
Sign In for Pricing
View Details NB600-276AF532 0.1 mL
Rabbit Polyclonal LEO1 Antibody [Alexa Fluor 532]
Sign In for Pricing
View Details